Adrenaline Rush … The Aftermath

1 min read

Frank Aprile

The potential for some agents to increase the risk of cardiovascular events has led to substantial changes in regulatory requirements for new anti-diabetic therapies. These requirements, while key to ensuring the cardiovascular safety of new agents, fail to emphasize the need to show clinical benefits, such as less visual impairment, less need for dialysis, or fewer cardiovascular events and deaths.

1 min read

Adrenaline Rush … The Aftermath

Frank Aprile

Tranexamic Acid and Convulsive Seizures After Off-pump Coronary Artery Bypass Surgery: the Role of Renal Insufficiency

Detection and decontamination of Mycobacterium Chimaera and Other Non-tuberculosis Mycobacteria in Heater–cooler Devices Used in Cardiopulmonary Bypass: a Manufacturer and National Guidelines Summary, and a Potential Resolution to the Problem Requiring Further Investigation

Diabetes Clinical Trials: Helped or Hindered by the Current Shift in Regulatory Requirements

Getting the latest perfusion news right to your inbox

Education

Resources

Sanibel Symposium

Epic Cardiovascular Services

Frank Aprile

Platelet Function Measurement-Based Strategy to Reduce Bleeding and Waiting Time in Clopidogrel-Treated Patients Undergoing Coronary Artery Bypass Graft Surgery

To initiate an amazing thing called Bypass

You may also like

Tranexamic Acid and Convulsive Seizures After Off-pump Coronary Artery Bypass Surgery: the Role of Renal Insufficiency

Detection and decontamination of Mycobacterium Chimaera and Other Non-tuberculosis Mycobacteria in Heater–cooler Devices Used in Cardiopulmonary Bypass: a Manufacturer and National Guidelines Summary, and a Potential Resolution to the Problem Requiring Further Investigation

Diabetes Clinical Trials: Helped or Hindered by the Current Shift in Regulatory Requirements

Getting the latest perfusion news right to your inbox

Education

Resources

Sanibel Symposium

Epic Cardiovascular Services